Skip to main content
. 2024 Jun 19;208(1):89–101. doi: 10.1007/s10549-024-07403-w

Table 3.

A selection of the significantly altered pathways according to proteins affected by treatment with MZ1 in MDA-MB-436

Pathway name p-value FDR
Interleukin-4 and interleukin-13 signaling 1.11e−16 4.31e−14
Constitutive signaling by aberrant PI3K 1.25e−08 6.88e−07
PIP3 activates AKT signaling 2.22e−08 1.07e−06
PI5P, PP2A and IER3 regulate PI3K/AKT signaling 9.23e−08 3.51e−06
Regulation of gene expression by Hypoxia-inducible Factor 1.23e−05 3.57e−04

Results are sorted according to p-value